HPCO Hempacco Co., Inc.: Company Short-Term Debt

Corporate emblem and logo of Hempacco (HPCO)

The daily price chart for Hempacco Co., Inc. (HPCO) reflects the performance of a company currently struggling with delisting risks while losing ground to industry behemoths. The business relies on expanding hemp products into retail chains and gas stations to attract consumers quitting nicotine. Partnerships with celebrities to create joint nicotine-free product lines provide additional growth, and the current metric stands at 0.00.

Hempacco Co Inc. (HPCO) - Company Short-Term Loans and Borrowings from 04/28/2023 to 09/07/2024

Summary analytical data breakdowns for Hempacco Co Inc. (HPCO)

- stock price and consensus target price:
Stock Price Hempacco|HPCO - Consensus Target
- company stock capitalization data:
Market Value Hempacco Co., Inc.|HPCO - Total Enterprise Value
- shareholders' equity book value data:
Accounting Value per Share Hempacco|HPCO - Accounting Value of Company|Market Capitalization to Book Value Ratio hempaccoinc.com|HPCO - Total Asset Value of Company
- debt and liquidity details:
Total Debt to Capital Hempacco Co., Inc.|HPCO - Long-Term Debt to Capital|Short-Term Debt to Equity Hempacco Co., Inc.|HPCO - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Hempacco Co., Inc.|HPCO - Company Long-Term Liabilities|Company Short-Term Debts Hempacco|Quick Ratio hempaccoinc.com
- earnings and valuation multiples indicators:
HPCO - Company Net Income
General company analysis:HPCO - Hempacco
Manufactured products of Hempacco Co., Inc.

At an early stage of product commercialization, Hempacco Co., Inc. utilizes targeted R&D solutions, making the amount of short-term borrowed capital a key indicator of operational liquidity. The current value of 0.00 reflects the volume of liabilities maturing within one year, allowing investors to assess the issuer's ability to service debt without massive revenue breakthroughs, which is critical for the stability of a micro-cap asset.

Competitor analysis

Indivior - Company Short-Term Debts|Collegium Pharma (COLL) - Company Current Liabilities|Cronos (CRON) - Company Short-Term Debt|Short-Term Debt Canopy Growth Corp. (CGC)|Company Current Liabilities HITI|ACB: Company Short-Term Loans and Borrowings|Company Short-Term Debts ACHV|SKYE: Current Liabilities|Company Short-Term Debts ANEB (Anebulo)|Company Short-Term Debts InterCure Ltd INCR|NTRB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NSRX (Nasus Pharma Ltd)|igcinc.us (IGC) - Company Short-Term Debt|Company Current Liabilities MIRA Pharmaceuticals, Inc.|FLGC (Flora Growth Corporation) - Company Short-Term Debts|IMCC: Company Short-Term Loans and Borrowings|Company Short-Term Debts ADIL|ARTL - Short-Term Debt|Company Short-Term Debt Ensysce Biosciences, Inc. ENSC|TTNP - Company Current Liabilities|GNLN - Company Short-Term Debt|Current Liabilities INM|AKAN: Company Short-Term Debts|enveric.com (ENVB) - Company Short-Term Debts|BGXX (Bright Green Corp.) - Company Short-Term Debts